Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alkermes (ALKS) Operating Leases (2019 - 2025)

Historic Operating Leases for Alkermes (ALKS) over the last 7 years, with Q3 2025 value amounting to $65.0 million.

  • Alkermes' Operating Leases fell 853.72% to $65.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $65.0 million, marking a year-over-year decrease of 853.72%. This contributed to the annual value of $69.4 million for FY2024, which is 837.02% down from last year.
  • Alkermes' Operating Leases amounted to $65.0 million in Q3 2025, which was down 853.72% from $66.2 million recorded in Q2 2025.
  • Over the past 5 years, Alkermes' Operating Leases peaked at $115.5 million during Q1 2021, and registered a low of $65.0 million during Q3 2025.
  • In the last 5 years, Alkermes' Operating Leases had a median value of $78.6 million in 2023 and averaged $85.5 million.
  • Its Operating Leases has fluctuated over the past 5 years, first skyrocketed by 1435.36% in 2021, then plummeted by 2676.12% in 2022.
  • Alkermes' Operating Leases (Quarter) stood at $104.2 million in 2021, then fell by 26.76% to $76.3 million in 2022, then fell by 0.76% to $75.7 million in 2023, then fell by 8.37% to $69.4 million in 2024, then fell by 6.35% to $65.0 million in 2025.
  • Its last three reported values are $65.0 million in Q3 2025, $66.2 million for Q2 2025, and $67.8 million during Q1 2025.